The message said that for patients with sinusistis, bronchitis and uncomplicated urinary tract infections who have other treatment options, the possible side effects of fluoroquinolone antibiotics outweigh the benefits.
In the 2015 State of the Union address, President Barack Obama announced the launch of the Precision Medicine Initiative — a bold new research effort that can be actuated by MD Labs' Rxight, a pharmacogenetic program.
Kenneth Parks will join the company on June 6 and will oversee all of Mylan’s global finance functions, including accounting and control, financial planning and analysis, investor relations, treasury and tax.
According to Veterans Affairs estimates, the price range for IUD costs to the military is $350 to $650 per device. Allergan will offer its IUD to the military treatment facilities and VA hospitals for $55.83.
Nuplazid (pimavanserin), from Acadia Pharmaceuticals, is the first medication to be approved to treat Parkinson’s-related psychosis, which affects some 40% of the 4-6 million patients with Parkinson’s disease.
SILVER SPRING, Md. — The Food and Drug Administration has approved Exelixis’ Cabometyx (cabozantinib) tablets, the company announced this week. Cabometyx is indicated to treat patients with advanced renal cell carcinoma who have previously received anti-angiogenic treatment.
The new indication for Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets; dasabuvir tablets) will allow it to be used for patients with genotype 1b chronic hepatitis C and compensated cirrhosis.